1 / 8

Challenges for the WHO Programme for International Drug Monitoring

Challenges for the WHO Programme for International Drug Monitoring. Mary Couper, Shanthi Pal, Mitsuko Imai, Maria Cuadrillero, Ana Garcia. WHO International Pharmacovigilance Programme Full and Associate members.

rayya
Télécharger la présentation

Challenges for the WHO Programme for International Drug Monitoring

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Challenges for the WHO Programme for International Drug Monitoring Mary Couper, Shanthi Pal, Mitsuko Imai, Maria Cuadrillero, Ana Garcia

  2. WHO International Pharmacovigilance Programme Full and Associate members

  3. An analysis of pharmacovigilance activities in 55 low- and middle-income countries • Sten Olssona, Shanthi Palb, Andy Stergachisc, Mary Coupera • Drug Safety 2009/2010 (a: WHO CC, Uppsala; b: WHO QSM; c: UWa)

  4. 3 tiers-approach for WHO Maintain as the cheapest, easiest, most sustainable method • As before (Spontaneous reporting) • Regional trainings • More than before (Active surveillance) • Tools • Handbooks • Nigeria, Tanzania, Ghana • As never before • Indicators • Fundraising (EuropeAid; BMGF; FP7) • Centres of excellence (Ghana, Morocco) • PVSF Cohort event monitoring; ECDD; EML; DTC Measure, support, optmise

More Related